2022 Annual Meeting | C44 - Child Neurology: Autism, Behavioral, and Developmental Issues

Date Sunday 04/03/22

Time 01:00 PM - 03:00 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Shafali Jeste, MD, FAAN

Topic(s) Child Neurology and Developmental Neurology

Learning Objectives Participants should become familiar with several aspects of research and clinical care in neurodevelopmental disorders, including diagnosis and management of comorbidities, genetics, bioamarkers, and precision health clinical trials. The speakers will share insights gained from recent studies in the field and then relate the evidence back to clinical practice and guidelines.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Medical Student

Teaching Styles Didactic

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:05 PM PDT	Introduction	Introduction Shafali Jeste, MD, FAAN
01:00 PM - 01:00 PM PDT	Speaker	walk in slides Shafali Jeste, MD, FAAN
01:05 PM - 01:25 PM PDT	Speaker	Neurological Comorbities of Neurodevelopment Disorders; Insomnia and Epilepsy Sarah J. Spence, MD, PhD
01:25 PM - 01:45 PM PDT	Speaker	Genetics of Neurodevelopmental Disorders: Implications for Precision Health Shafali Jeste, MD, FAAN
01:45 PM - 02:05 PM PDT	Speaker	Motor Dysfunction in Neurodevelopmental Disorders: Research and Clinical Applications Rujuta B. Wilson, MD
02:05 PM - 02:25 PM PDT	Speaker	Biomarkers for Improving Clinical Trials in Neurodevelopmental Disorders Sara Webb, PhD
02:25 PM - 03:00 PM PDT	Discussion	Panel Discussion & Questions and Answers Shafali Jeste, MD, FAAN, Rujuta B. Wilson, MD, Sarah J. Spence, MD, PhD

Faculty Disclosures
Sarah J. Spence, MD, PhD	Dr. Spence has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for dup15qalliance. The institution of Dr. Spence has received research support from Hoffman La Roche. The institution of Dr. Spence has received research support from NIH.
Shafali Jeste, MD, FAAN	Dr. Jeste has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Roche Pharmaceuticals. Dr. Jeste has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Roche Pharmaceuticals. Dr. Jeste has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Ionis Pharmaceuticals. Dr. Jeste has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for AAN Continuum. The institution of Dr. Jeste has received research support from NIH. The institution of Dr. Jeste has received research support from DoD. The institution of Dr. Jeste has received research support from Dup15q Alliance.
Rujuta B. Wilson, MD	Dr. Wilson has nothing to disclose.
Sara Webb, PhD	Sara Webb, PhD has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Simons Foundation SPARK Research Advisory Board. Sara Webb, PhD has received research support from NIH. Sara Webb, PhD has received research support from Simons Foundation.

��ɫ��

��ɫ��